Artificial Intelligence for non-invasive brain cancer classification based on ctDNA mutational profiles- 1027 1124 01
IMMUSIGN-Using machine learning and a living immune repository to detect disease-specific and anti-tumor immune signatures
Establishing a bioinformatics platform for non-invasive classification of brain cancers by ctDNA- 1027 1164 01
Using artificial intelligence to decipher and manipulate cellular growth patterns in acute myeloid leukemia (AI@AML)
Development of a machine-learning approach for leukemia cell – mcroenvironment interactions
Detection of disease-specific signatures in B cell repertories of lymphomas using machine learning
Funded By Mertelsmann Foundation
The Mertelsmann Foundation has made improving the fight against cancer with the help of innovative methods its main concern. To this end, it brings together cancer research and artificial intelligence. In doing so, it relies on interdisciplinary collaboration between experimental and clinical oncology, artificial intelligence and philosophy.